Pegylated Interferon(Peg-IFN) in Reducing Relapse Rate in Patients After Discontinuation of NUC Therapy

Clinical trial NCT02594293 · COMPLETED

Trial details

NCT number: NCT02594293
Sponsor: Huashan Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2015-10-01
Primary completion: 2022-09-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.